Biocide Tolerance, Biofilm Formation, and Efflux Pump Activity in Clinical Isolates of Trichosporon asahii
Open Access
- 6 August 2025
- journal article
- research article
- Published by MDPI AG in Infectious Disease Reports
- Vol. 17 (4) , 97
Abstract
Background: Trichosporon spp. are opportunistic fungi, capable of causing infection, especially in critically ill individuals who often use broad-spectrum antibiotics, invasive devices, and have comorbidities. Objectives The aim of this study was to analyze individuals’ clinical characteristics, evaluate tolerance to biocides, as well as biofilm formation and efflux pump activity in isolates of Trichosporon asahii. Methods: Clinical isolates of T. asahii collected between 2020 and 2023 from both hospitalized and non-hospitalized individuals, of both sexes, regardless of age, were tested for tolerance to sodium hypochlorite, hydrogen peroxide, benzalkonium chloride, and ethyl alcohol. Efflux pump activity was also assessed using ethidium bromide, and biofilm formation was measured with the Safranin test. Clinical parameters such as outcomes, source, and length of hospitalization were analyzed through electronic medical records. Results: A total of 37 clinical isolates of T. asahii were identified. Thirty-three (83.8%) isolates were from hospitalized individuals, with 81.82% collected in ICUs, an average hospital stay of 35 days, and a mortality rate of 51.6%. The tested strains displayed the largest mean inhibition zone for 2% sodium hypochlorite, indicating lower tolerance. A high level of efflux pump expression was detected among clinical isolates. Biofilm formation was detected in 25/67.5% of the isolates. Conclusions: These findings highlight the clinical relevance of T. asahii, particularly in critically ill individuals, and underscore the pathogen’s ability to tolerate biocides, express efflux pumps, and form biofilms, all of which may contribute to its persistence and pathogenicity in hospital environments. Enhanced surveillance and effective microbial control measures are essential to mitigate the risks associated with T. asahii infections.Keywords
Funding Information
- Federal University of Juiz de Fora (UFJF)
- Graduate Program in Biological Sciences (PPGCBIO)
- Cortes Villela Laboratory
- FAPEMIG
- CAPES
This publication has 44 references indexed in Scilit:
- Clinical significance of nosocomial Trichosporon asahii in urine: A retrospective cohort studyInfectious Diseases Now, 2025
- Effect of prolonged exposure to disinfectants in the antimicrobial resistance profile of relevant micro-organisms: a systematic reviewJournal of Hospital Infection, 2024
- Adhesion and biofilm formation by two clinical isolates of Trichosporon Cutaneum in various environmental conditionsBrazilian Journal of Microbiology, 2024
- World Health Organization World Hand Hygiene Day, 5 May 2024. SAVE LIVES: Clean Your Hands campaign: Promoting knowledge and capacity building on infection prevention and control, including hand hygiene, among health and care workersInfection Control & Hospital Epidemiology, 2024
- Risk factors, antifungal susceptibility, complications, and outcome of Candida auris bloodstream infection in a tertiary care center in the western region of Saudi ArabiaJournal of Infection and Public Health, 2023
- Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASMThe Lancet Infectious Diseases, 2021
- Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.Mycopathologia, 2019
- Infección nosocomial por Trichosporon asahii en un paciente quemado críticoRevista Iberoamericana de Micologia, 2015
- Towards an integrated phylogenetic classification of theTremellomycetesStudies in Mycology, 2015
- Efficacy and Safety of Nadifloxacin for Bacterial Skin Infections: Results from Clinical and Post-Marketing StudiesDermatology and Therapy, 2014